The pandemic made clear to all of us how essential the work of the life sciences sector is. But can it operate more efficiently through digital…
With the benefit of hindsight, one remarkable aspect of the COVID crisis was the speed with which vaccines passed through regulatory approval processes to take on the emergency of the pandemic. Approvals that might more commonly have taken years under normal circumstances ended up in mass production sign-offs within months, moving at a speed not typically associated with the life sciences industry.